Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex
Cost-Effectiveness Analysis of Canagliflozin 300 mg Versus Dapagliflozin 10 mg Added to Metformin in Patients with Type 2 Diabetes in the United States
PaperCitations, authors & open-access status
Cost-Effectiveness Analysis of Canagliflozin 300 mg Versus Dapagliflozin 10 mg Added to Metformin in Patients with Type 2 Diabetes in the United States is a paper indexed in ScholarIQ from OpenAlex. ScholarIQ records 24 citations, 2018 year and gold oa status.
24
Citations
2018
Year
gold
OA Status